CD4 and depressive disorder: As outlined in our current working hypothesis (Figure 6), anti-angiogenic imbalance leads to increased CD4+ T cells, leading to increased production of inflammatory cytokines, cerebrovascular impairment and decreased integrity of the blood–brain barrier, all of which leads to neuroinflammation, which contributes to the development of anxiety, depression and cognitive impairment.